Impact of PARP inhibitors on progression-free survival in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective analysis

Abstract Objective Poly (ADP-ribose) polymerase (PARP) inhibitors such as olaparib and niraparib have shown promise in extending progression-free survival (PFS) in patients with platinum-sensitive recurrent (PSR) epithelial ovarian cancer. In this retrospective study, we aimed to present our own dat...

Full description

Bibliographic Details
Published in:World Journal of Surgical Oncology
Main Authors: Yumei Zhou, Junfen Xu
Format: Article
Language:English
Published: BMC 2024-10-01
Subjects:
PSR epithelial ovarian cancer
PARP inhibitors
Maintenance therapy
PFS
Online Access:https://doi.org/10.1186/s12957-024-03562-8

Internet

https://doi.org/10.1186/s12957-024-03562-8

Similar Items